Merck & Co. Inc. (NYSE:MRK) has won federal approval for a new type of sleeping pill designed to help people with insomnia stay asleep. Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its net profit margin is 12.90% and weekly performance is 5.64%. On last trading day company shares ended up $58.78. Merck & Co. Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is 1.52%.
Yesterday, Pfizer Inc. (NYSE:PFE) announced it had won the approval of an influential US advisory panel, for its drug Prevnar 13. Pfizer Inc. (NYSE:PFE) shares increased 1.84% in last trading session and ended the day at $28.73. PFE Gross Margin is 81.30% and its return on assets is 17.10%. Pfizer Inc. (NYSE:PFE) quarterly performance is -0.28%.
Eaton Vance Limited Duration Income Fund (EVV) will begin trading ex-dividend on August 07, 2014. A cash dividend payment of $0.1017 per share is scheduled to be paid on August 18, 2014. Shareholders who purchased EVV stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 20th quarter that EVV has paid the same dividend. At the current stock price of $14.96, the dividend yield is 8.16%. On 14 August, Eaton Vance Limited Duration Income Fund (NYSEMKT:EVV) shares increased 0.54% and was closed at $15.00. EVV EPS growth in last 5 year was 19.90%. Eaton Vance Limited Duration Income Fund (NYSEMKT:EVV) year to date (YTD) performance is 3.45%.
On July 31, 2014 CEVA Inc. (NASDAQ:CEVA), the leading licensor of DSP-based IP platforms for vision, audio, communications and connectivity, announced its financial results for the second quarter ended June 30, 2014. CEVA Inc. (NASDAQ:CEVA) ended the last trading day at $14.77. Company weekly volatility is calculated as 2.84%and price to cash ratio as 2.51. CEVA Inc. (NASDAQ:CEVA) showed a weekly performance of 3.72%.
Mesabi Trust (NYSE:MSB) shares increased 0.43% in last trading session and ended the day on $18.63. MSB return on assets is 252.80%. Mesabi Trust (NYSE:MSB) quarterly performance is -3.77%.